Valerie Morisset's Insider Trades & SAST Disclosures
Valerie Morisset's most recent trade in Climb Bio Inc. was a trade of 50,000 Common Stock done at an average price of $7.2 . Disclosure was reported to the exchange on July 19, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Valerie Morisset.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Climb Bio Inc. | Valerie Morisset | EVP, R&D AND CSO | Sale of securities on an exchange or to another person at price $ 7.24 per share. | 19 Jul 2024 | 50,000 | 100,322 | - | 7.2 | 362,000 | Common Stock |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D AND CSO | Sale of securities on an exchange or to another person at price $ 8.07 per share. | 19 Jul 2024 | 39,005 | 61,317 | - | 8.1 | 314,770 | Common Stock |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D AND CSO | Sale of securities on an exchange or to another person at price $ 7.98 per share. | 19 Jul 2024 | 30,000 | 31,317 | - | 8.0 | 239,400 | Common Stock |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D AND CSO | Sale of securities on an exchange or to another person at price $ 7.09 per share. | 19 Jul 2024 | 10,201 | 150,322 | - | 7.1 | 72,325 | Common Stock |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D AND CSO | Sale of securities on an exchange or to another person at price $ 6.93 per share. | 17 Jul 2024 | 38,576 | 160,523 | - | 6.9 | 267,332 | Common Stock |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D AND CSO | Sale of securities on an exchange or to another person at price $ 6.91 per share. | 17 Jul 2024 | 3,207 | 199,099 | - | 6.9 | 22,160 | Common Stock |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D AND CSO | Sale of securities on an exchange or to another person at price $ 7.13 per share. | 16 Jul 2024 | 50,000 | 202,306 | - | 7.1 | 356,500 | Common Stock |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D AND CSO | Sale of securities on an exchange or to another person at price $ 7.07 per share. | 12 Jul 2024 | 50,000 | 294,683 | - | 7.1 | 353,500 | Common Stock |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D AND CSO | Sale of securities on an exchange or to another person at price $ 7.01 per share. | 12 Jul 2024 | 42,377 | 252,306 | - | 7.0 | 297,063 | Common Stock |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D AND CSO | Sale of securities on an exchange or to another person at price $ 7.11 per share. | 09 Jul 2024 | 50,000 | 344,683 | - | 7.1 | 355,500 | Common Stock |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D AND CSO | Sale of securities on an exchange or to another person at price $ 6.83 per share. | 09 Jul 2024 | 50,000 | 394,683 | - | 6.8 | 341,500 | Common Stock |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D AND CSO | Sale of securities on an exchange or to another person at price $ 6.66 per share. | 09 Jul 2024 | 5,931 | 444,683 | - | 6.7 | 39,500 | Common Stock |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D AND CSO | Sale of securities on an exchange or to another person at price $ 7.06 per share. | 05 Jul 2024 | 12,342 | 450,614 | - | 7.1 | 87,135 | Common Stock |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D AND CSO | Sale of securities on an exchange or to another person at price $ 6.76 per share. | 01 Jul 2024 | 50,000 | 462,956 | - | 6.8 | 338,000 | Common Stock |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D AND CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 7,649 | 512,956 | - | 0.0 | 2 | Common Stock |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D AND CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 7,649 | 10,198 | - | - | Stock Option (Right to Buy) | |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D AND CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2024 | 17,847 | 505,307 | - | 0.0 | 4 | Common Stock |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D AND CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2024 | 17,847 | 28,046 | - | - | Stock Option (Right to Buy) | |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D AND CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Sep 2023 | 15,297 | 487,460 | - | 0.0 | 3 | Common Stock |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D AND CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Sep 2023 | 15,297 | 45,893 | - | - | Stock Option (Right to Buy) | |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D AND CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Sep 2023 | 5,431 | 0 | - | - | Stock Option (Right to Buy) | |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D AND CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Sep 2023 | 5,431 | 472,163 | - | 0.0 | 11 | Common Stock |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D and CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 255,219 | 405,541 | - | 0.0 | 510 | Common Stock |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D and CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 255,219 | 5,431 | - | - | Stock Option (Right to Buy) | |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D and CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 61,191 | 61,190 | - | - | Stock Option (Right to Buy) | |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D and CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 61,191 | 466,732 | - | 0.0 | 12 | Common Stock |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2022 | 170,000 | 170,000 | - | - | Stock Option (Right to Buy) | |
| Climb Bio Inc. | Valerie Morisset | EVP, R&D and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 170,000 | 170,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges